Personal information

Websites & social links

Dr. Howard Bruckner Linkedin

Countries

United States

Biography

- Experienced Chief Researcher with a demonstrated history of working in the hospital & health care industry.

- Skilled in Clinical Research (for resistant and difficult tumors).

- Consulting, Medical Education, Reviewer, Coaching, Translational Medicine (drug interactions, next-generation of personalized medicine tests), and Medical Devices.

- Strong research professional.

- NIH, Yale, Sinai international cooperative group consultant.

- 150 + peer-reviewed articles.

Activities

Collapse all

Employment (12)

MZB Center for Cancer Research : New York, New York, US

2001 to present | Physician, Owner, Director (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Bruckner Oncology: Bronx, New York, US

2008 to 2021 | Chief Physician (Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

New York Downtown Hospital : New York, New York , US

2010 to 2012 | Chief (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Saint Vincent Catholic Medical Centers: New York, NY, US

2008 to 2010 | Attending Physician (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Cabrini Medical Center: New York, New York, US

2007 to 2008 | Director (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Oncovation Laboratory : New York, New York, US

2002 to 2008 | Chief Scientific Officer (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Lutheran Medical Center: Brooklyn, New York, US

2001 to 2007 | Director (Department of Medical Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

St. Luke's-Roosevelt Hospital Center: New York, New York, US

1999 to 2001 | Director (Department of Oncology Therapeutics)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

The Mount Sinai Hospital : New York, New York, US

1989 to 1999 | Attending Physician (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

The Mount Sinai Hospital : New York, New York, US

1977 to 1989 | Associate Attending Physician (Department of Oncology)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Mount Sinai School of Medicine: New York, New York, US

1975 to 1977 | Assistant Professor (Department of Medicine and Neoplastic Diseases)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Mount Sinai School of Medicine: New York, New York, US

1973 to 1975 | Associate Professor (Derpartment of Medicine)
Employment
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Education and qualifications (9)

American Board of Internal Medicine: Philadelphia, Pennsylvania, US

Diplomat (Department of Internal Medicine )
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

American Board of Internal Medicine: Philadelphia, Pennsylvania, US

Diplomat (Subspeciality of Medical Oncology )
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Yale School of Medicine: New Haven, CT, US

1972 to 1973 (Department of Medical Oncology, Fellowship )
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Yale School of Medicine: New Haven, CT, US

1970 to 1971 (Department of Internal Medicine, Fellowship )
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Albert Einstein College of Medicine: The Bronx, New York, US

1969 to 1970 (Medical Resident)
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

National Cancer Institute: Bethesda, Maryland , US

1967 to 1968 (Department of Chemistry, Research Associate )
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Albert Einstein College of Medicine: The Bronx, New York, US

1966 to 1967 (Medical Intern)
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Albert Einstein College of Medicine: The Bronx, New York, US

1962 to 1966 | MD
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Brooklyn College: Brooklyn, NY, US

1958 to 1962 | BS
Education
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Professional activities (9)

American Pancreatic Association: Manhattan Beach, California, US

1992 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Gynecologic Oncology Group: Crofton, Maryland, US

1990 to present | Founding Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

National Surgical Adjuvant Project for Breast and Bowel Cancers: Pittsburgh, Pennsylvania, US

1987 to present | Consultant for the Chemotherapy Committee
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

International Gynecologic Cancer Society: Austin, TX, US

1986 to present | Founding Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

New York Academy of Sciences: New York, New York, US

1979 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

American Federation for Clinical Research : Beverly , Massachusetts, US

1976 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

American Society of Clinical Oncology: Alexandria, Virginia, US

1975 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Gastrointestinal Tumor Study Group: Orlando, Florida, US

1973 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

American Association For Cancer Research: Philadelphia, Pennsylvania, US

1972 to present | Member
Membership
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Works (50 of 129)

Items per page:
Page 1 of 3

Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times

PLOS ONE
2022-11-02 | Journal article
DOI: 10.1371/journal.pone.0276492
Contributors: Howard W. Bruckner; Md Sazzad Hassan; Fred Bassali; Elisheva Dusowitz; Daniel Gurell; Abe Book; Robert De Jager
Source: check_circle
Crossref

Hypoxia enhanced the differentiation of human bone marrow-derived mesenchymal stem cells into dopaminergic neurons

2010-11-26 | Journal article
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Factors influencing cytomegalovirus reactivation after stem cell transplantation and preclinical studies towards cellular immunotherapy.

2010-06-18 | Journal article
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer.

Anti-cancer drugs
2007-03-01 | Journal article
DOI: 10.1097/cad.0b013e3280121334
PMID: 17264757
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience.

International journal of oncology
2006-11-01 | Journal article
PMID: 17016635
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemotherapeutic management of small bowel adenocarcinoma associated with Crohn's disease.

Journal of chemotherapy (Florence, Italy)
2006-10-01 | Journal article
DOI: 10.1179/joc.2006.18.5.545
PMID: 17127233
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Bevacizumab as treatment for chemotherapy-resistant pancreatic cancer.

Anticancer research
2005-09-01 | Journal article
PMID: 16101193
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemosensitivity Testing as an Aid to Anti-Cancer Drug and Regimen Development

Chemosensitivity Testing in Oncology
2003 | Book chapter
DOI: 10.1007/978-3-642-19022-3_11
Part of ISBN: 9783642624124
Part of ISBN: 9783642190223
Part of ISSN: 0080-0015
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.

Archives of internal medicine
2003-11-01 | Journal article
DOI: 10.1001/archinte.163.20.2469
PMID: 14609783
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.

Hematology/oncology clinics of North America
2002-02-01 | Journal article
DOI: 10.1016/s0889-8588(01)00004-1
PMID: 12063823
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

British journal of cancer
2001-06-01 | Journal article
DOI: 10.1054/bjoc.2001.1814
PMID: 11384106
PMC: PMC2363673
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.

The Surgical clinics of North America
2001-06-01 | Journal article
DOI: 10.1016/s0039-6109(05)70155-9
PMID: 11459283
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer: A Review.

International journal of gastrointestinal cancer
2001-01-01 | Journal article
PMID: 12754399
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.

The oncologist
2001-01-01 | Journal article
DOI: 10.1634/theoncologist.6-6-488
PMID: 11743211
Source: Self-asserted source
Howard W Bruckner, HW Bruckner
grade
Preferred source (of 2)‎

Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients.

Nutrition and cancer
2001-01-01 | Journal article
DOI: 10.1207/s15327914nc391_12
PMID: 11588907
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Current surgical therapy for carcinoma of the pancreas.

Journal of clinical gastroenterology
2000-09-01 | Journal article
DOI: 10.1097/00004836-200009000-00004
PMID: 10993424
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
Source: Self-asserted source
Howard W Bruckner, HW Bruckner
grade
Preferred source (of 2)‎

Pancreatic duct cell carcinoma with positive 111In Octreotide uptake.

Journal of experimental & clinical cancer research : CR
2000-06-01 | Journal article
PMID: 10965825
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Eccrine sweat gland carcinoma: a case report and review of diagnosis and treatment.

Connecticut medicine
2000-05-01 | Journal article
PMID: 10860232
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.

British journal of cancer
1999-03-01 | Journal article
DOI: 10.1038/sj.bjc.6690226
PMID: 10188884
PMC: PMC2362707
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement.

Nutrition and cancer
1999-01-01 | Journal article
DOI: 10.1207/s15327914nc340109
PMID: 10453443
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

British journal of cancer
1998-12-01 | Journal article
DOI: 10.1038/bjc.1998.710
PMID: 9836481
PMC: PMC2063202
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial.

Clinical cancer research : an official journal of the American Association for Cancer Research
1997-09-01 | Journal article
PMID: 9815839
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Combined modality therapy for stage II and stage III pancreatic carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1997-08-01 | Journal article
DOI: 10.1200/jco.1997.15.8.2920
PMID: 9256136
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer

British Journal of Cancer
1996-09 | Journal article
DOI: 10.1038/bjc.1996.458
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Definitive surgery for duct cell carcinomas of the pancreas.

Journal of the American College of Surgeons
1996-09-01 | Journal article
PMID: 8784327
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.

Anti-cancer drugs
1996-08-01 | Journal article
DOI: 10.1097/00001813-199608000-00002
PMID: 8913430
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Tumor markers in patients with pancreatic carcinoma

Cancer
1996-07-01 | Journal article
DOI: 10.1002/(sici)1097-0142(19960701)78:1<57::aid-cncr10>3.0.co;2-6
Part of ISSN: 0008-543X
Part of ISSN: 1097-0142
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay.

Anti-cancer drugs
1995-10-01 | Journal article
DOI: 10.1097/00001813-199510000-00010
PMID: 8845481
Source: Self-asserted source
Howard W Bruckner, HW Bruckner
grade
Preferred source (of 3)‎

Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine

Medical and Pediatric Oncology
1994 | Journal article
DOI: 10.1002/mpo.2950220607
Part of ISSN: 0098-1532
Part of ISSN: 1096-911X
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.

Journal of bioluminescence and chemiluminescence
1994-11-01 | Journal article
DOI: 10.1002/bio.1170090604
PMID: 7879653
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors.

Gastrointestinal endoscopy
1994-05-01 | Journal article
DOI: 10.1016/s0016-5107(94)70065-6
PMID: 8056236
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome

British Journal of Cancer
1994-03 | Journal article
DOI: 10.1038/bjc.1994.114
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

A somatostatin analogue (SMS 201-995) alters the toxicity of 5-fluorouracil in Swiss mice.

Anticancer research
1993-09-01 | Journal article
PMID: 8239519
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1993-08-01 | Journal article
DOI: 10.1200/jco.1993.11.8.1517
PMID: 8393097
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Survival after combined modality therapy for pancreatic cancer.

Journal of clinical gastroenterology
1993-04-01 | Journal article
DOI: 10.1097/00004836-199304000-00006
PMID: 8505490
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemosensitivity testing in ovarian cancer.

Cancer
1993-02-01 | Journal article
DOI: 10.1002/cncr.2820710428
PMID: 8431897
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct.

Acta oncologica (Stockholm, Sweden)
1993-01-01 | Journal article
DOI: 10.3109/02841869309092442
PMID: 8260180
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Combined modality therapy increasing local control of pancreatic cancer.

Cancer investigation
1993-01-01 | Journal article
DOI: 10.3109/07357909309024847
PMID: 8485645
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Treatment of a large high-grade neurofibrosarcoma with concomitant vinblastine, doxorubicin, and radiotherapy.

The Mount Sinai journal of medicine, New York
1992-10-01 | Journal article
PMID: 1435843
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Clostridium difficile diarrhea induced by cancer chemotherapy.

Archives of internal medicine
1992-08-01 | Journal article
DOI: 10.1001/archinte.1992.00400200139025
PMID: 1497405
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1992-04-01 | Journal article
DOI: 10.1200/jco.1992.10.4.549
PMID: 1548520
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Adjuvant therapy with hepatic irradiation plus fluorouracil in colon carcinoma. The Gastrointestinal Tumor Study Group.

International journal of radiation oncology, biology, physics
1991-10-01 | Journal article
DOI: 10.1016/0360-3016(91)90270-e
PMID: 1938512
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

BMJ (Clinical research ed.)
1991-10-01 | Journal article
DOI: 10.1136/bmj.303.6807.884
PMID: 1834291
PMC: PMC1671193
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Chemotherapy of advanced cancer of the colon and rectum.

Seminars in oncology
1991-10-01 | Journal article
PMID: 1925632
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Folate biochemical modulation regimen for the treatment of gastric cancer.

Journal of clinical gastroenterology
1991-08-01 | Journal article
DOI: 10.1097/00004836-199108000-00005
PMID: 1918843
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience.

Cancer treatment reviews
1991-03-01 | Journal article
DOI: 10.1016/0305-7372(91)90025-u
PMID: 1904310
Source: Self-asserted source
Howard W Bruckner, HW Bruckner
grade
Preferred source (of 2)‎

A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. The Gastrointestinal Tumor Study Group.
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Pulmonary carcinoid presenting as multiple subcutaneous nodules.

Tumori
1990-02-01 | Journal article
DOI: 10.1177/030089169007600111
PMID: 2321273
Source: Self-asserted source
Howard W Bruckner, HW Bruckner

Dose-dependent leucovorin efficacy with an intermittent high-dose 5-fluorouracil schedule.

Cancer investigation
1990-01-01 | Journal article
DOI: 10.3109/07357909009012048
PMID: 2207756
Source: Self-asserted source
Howard W Bruckner, HW Bruckner
Items per page:
Page 1 of 3
How many people are using ORCID?